Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience.
Saved in:
| Title: | Report of National Brain Tumor Society roundtable workshop on innovating brain tumor clinical trials: building on lessons learned from COVID-19 experience. |
|---|---|
| Authors: | Lee EQ; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Selig W; WSCollaborative, McLean, Virginia, USA., Meehan C; National Brain Tumor Society, Newton, Massachusetts, USA., Bacha J; Edison Oncology Holding Corp., Menlo Park, California, USA., Barone A; Office of Hematology and Oncology Products at the Food and Drug Administration, Silver Spring, Maryland, USA., Bloomquist E; Office of Biostatistics, Center for Drug Evaluation and Research at the Food and Drug Administration, Silver Spring, Maryland, USA., Chang SM; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA., de Groot JF; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Galanis E; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA., Hassan I; Agios Pharmaceuticals, Cambridge, Massachusetts, USA., Kalidas C; Bayer Pharmaceuticals, Hillsborough, New Jersey, USA., Khasraw M; Preston Robert Tisch Brain Tumor Center at Duke, Departments of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA., Kvedar JC; Department of Dermatology at Massachusetts General Hospital, Boston, Massachusetts, USA., Lassman AB; Department of Neurology and Herbert Irving Comprehensive Cancer Center, New-York Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA., Puduvalli V; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sahebjam S; Department of Neuro-Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA., Schwamm LH; Department of Neurology at Massachusetts General Hospital, Boston, Massachusetts, USA., Tamir S; Karyopharm Therapeutics, Inc., Newton, Massachusetts, USA., Welch M; Department of Neurology and Herbert Irving Comprehensive Cancer Center, New-York Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA., Yung WKA; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Zadeh G; MacFeeters-Hamilton Center for Neuro-Oncology, Princess Margaret Cancer Center, Toronto, Ontario, Canada., Arons D; National Brain Tumor Society, Newton, Massachusetts, USA., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. |
| Source: | Neuro-oncology [Neuro Oncol] 2021 Aug 02; Vol. 23 (8), pp. 1252-1260. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1523-5866 |
|---|---|
| DOI: | 10.1093/neuonc/noab082 |
